Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Cresco

Cannabis Chart of the Week: Is The SAFE+ Act Scaring Away The Shorts?

Cannabis stocks have rallied over the last several weeks as discussion of the Schumer/Booker bill and the likelihood of a pivot to a SAFE+ Banking Act dominated the news. Articles in the press have made it seem as though short sellers had been vigorously covering their positions.

Benzinga

How To Get In Touch With The 5 Biggest Cannabis Operators In The US

While there’s no doubt that the federal legalization of marijuana would make the industry explode, current trends shouldn’t be underestimated.

Benzinga

What Do Cannabis And Mortgage Banking Have In Common? A Lot, According To Charlie Bachtell Of Cresco Labs

After the sweeping success of Benzinga's 4/20 Miami event, the Benzinga Cannabis Capital Conference is heading back to Chicago.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

As flourishing cannabis industry expands to pricier, high-profile sites, social equity applicants left behind

When medical marijuana sales began in Illinois in 2014, cannabis firms typically chose unobtrusive buildings, sometimes hidden away in industrial parks, to sell the controversial product.

Chicago Tribune

Cresco Lab's 1Q Results After Conference Call, Analyst Opines

The Analyst Following Cresco Labs’ (OTC: CRLBF) (CSE:CL) conference call, Pablo Zuanic, from Cantor Fitzgerald kept an "Overweight" rating and maintained a 12-month price target of $19.

Benzinga

Cresco Labs Q1 Revenue Grows 20%, Here Are The Details

Cresco Labs Inc. (OTCQX: CRLBF) (CSE: CL) (FSE:6CQ) released its financial results for the three months ended March 31, 2022, revealing revenue of $214 million, up 20% year-over-year.

Benzinga

Columbia Care: Challenging 1Q, Stock Is Now Tied to Cresco Deal Analyst Says

The Analyst Pablo Zuanic, from Cantor Fitzgerald, rated Columbia Care Inc. (OTC: CCHWF) as Overweight with a price target of $5.10.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Cresco Labs Brings Its Cannabis Brand FloraCal Farms To Illinois

Cresco Labs (OTCQX:CRLBF) (CSE:CL) launched its premium craft brand FloraCal Farms, which features curated flower, live rosin vape and live rosin concentrate formats now available at all Illinois Sunnyside stores and other retailers ahead of the 420 cannabis holiday.

Benzinga

Cannabis Roundup (Week of 3/29): Is Biden a Marijuana Friend or Foe?

The optimism from cannabis advocates following the election of a Democrat to the presidency is eroding in D.C. following President Joe Biden's latest budget proposal.

The Street

Cannabis M&A Activity On Fire: But Is It What Was Expected? Experts Say, Look At Q1 Earnings

Consolidation of the cannabis industry is inevitable as the market matures. Heading into 2022, numerous forecasts predicted another flurry of M&A activity after an energized 2021. With nearly three months of the year complete, opinions are split on M&A activity so far.

Benzinga

Analyst On Cresco's Deal With Columbia Care And Earnings Results For Q4 2021

The Analyst: Pablo Zuanic, from Cantor Fitzgerald, rated Cresco Labs, Inc. (OTC: CRLBF) as Overweight with a price target of $19.00.

Benzinga

Cresco agrees to buy Columbia Care in all-stock cannabis merger valued at $2 billion

Chicago-based Cresco Labs, one of the largest publicly traded cannabis companies in the U.S., may get a lot bigger after announcing its proposed acquisition Wednesday of Columbia Care in an all-stock merger valued at about $2 billion.

Chicago Tribune

Chicago’s Cresco Labs to become nation’s largest weed firm with planned $2B takeover

Cresco Labs announced plans Wednesday to take over Manhattan-based Columbia Care, marking the latest high-profile consolidation affecting Illinois’ booming cannabis business.

Chicago Sun-Times

Cannabis Dispensary Roundup: Element 7, Halo Collective, Cresco, Budega, Parallel, Great Barrington, FIKA

Element 7 Launches Its First Central Valley Cannabis Dispensary In Firebaugh Element 7 opened its newest retail cannabis concept store in the heart of California's Central Valley last weekend.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Cresco Labs Financial Results: Record Revenue $822M For 2021, 73% YoY Increase

Cresco Labs Inc. (OTCQX: CRLBF) (CSE: CL) (FSE:6CQ) released its financial results for the three months and year ended December 31, 2021. Fiscal Year 2021 Financial Highlights

Benzinga

Cresco Labs To Acquire Columbia Care For $2.1B, Becoming Largest Cannabis Company In US

U.S.

Benzinga

Cresco Receives Green Light To Build New Gigantic Marijuana Facility To Supply NYC's Demand

The planning board in the Town of Wawarsing in Ulster County, New York has approved plans for Valley Agriceuticals LLC, whose parent company is Cresco Labs (CSE: CL) (OTCQX: CRLBF), to build a 380,000 square-foot marijuana facility,

Benzinga

Cresco Labs Launches Expansive Marijuana Product Lineup In Florida

Cresco Labs (CSE:CL) (OTCQX: CRLBF) has launched its High Supply, Good News, and Remedi brands in Florida and also released a new edibles brand, Sunnyside Chews, available only in the state.

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 Cannabis Stocks That Could More Than Triple in Value in 2022, According to Wall Street

The cannabis industry achieved impressive growth last year. And with increased public and corporate support, the industry is expected to maintain its momentum this year. Therefore, Wall Street analysts expect cannabis stocks Trulieve Cannabis (TCNNF), Cresco Labs (CRLBF), and Columbia Care (CCHWF) to deliver substantial returns in the coming months.…

Benzinga

Cannabis Dispensary Roundup: Cresco Labs, High Tide, Khiron, Cordova Cann

Cresco Labs Opens 14th Florida Medical Cannabis Dispensary

StockNews.com

4 Overvalued Cannabis Stocks Investors Should Continue to Avoid

The cannabis industry witnessed solid growth last year on a legalization wave and increasing demand for innovative cannabis products. But while the industry is expected to maintain its momentum this year, some cannabis stocks are trading at lofty valuations despite their companies’ relatively weak growth prospects. So, we think overvalued…

Benzinga

Cresco Labs Launches Khalifa Kush Products At Cookies Cannabis Dispensaries Across California

Cresco Labs (CSE: CL) (OTCQX: CRLBF) announced Friday that flower and pre-rolls from Khalifa Kush are available for sale at Cookies stores across California.

Benzinga

Cresco Labs Cancels Acquisition Of 'Top-Performing' Marijuana Dispensary In Maryland

Vertically integrated cannabis company Cresco Labs (CSE: CL) (OTCQX: CRLBF) will not acquire Blair Wellness, LLC. a Baltimore Maryland medical cannabis dispensary. Cresco, based in Chicago, Illinois confirmed on Wednesday that it had terminated

Kiplinger

Best Marijuana Stocks to Buy: Cannabis Stocks for Investing

The best marijuana stocks have been put through the wringer for years. But with U.S. cannabis sales on the rise, these picks could finally have their day in the sun.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.